IPO registrations (S-1, F-1) · Registrants

CASI Pharmaceuticals, Inc (DE)

SEC CIK

895051 · filings on EDGAR ↗

Name on the registration

ENTREMED INC

Former names

CASI Pharmaceuticals, Inc. (2014–2023); ENTREMED INC (1996–2014)

Registration

Form S-1, first filed 1996-05-17, last 1996-06-11; 0 initial registrations, 3 amendments

Outcome

Final prospectus filed 1996-06-13

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Incorporated in

DE

Business address

9620 MEDICAL CENTER DR, STE 300, Rockville, MD 20850

EIN

58-1959440

EDGAR entity type

operating

Insiders and CEO pay

CASI Pharmaceuticals, Inc (DE) on the corporate pages

Offering terms

Proposed price range

$14.00–$16.00 per share (S-1/A filed 1996-06-11)

Shares offered

3,200,000

Listing

Nasdaq under the symbol ENMD

Lead underwriters

Allen & Company (705,000 shares); Dillon, Read & CO. Inc (705,000 shares); Volpe, Welty & Company (705,000 shares)

Syndicate

Bear Stearns (75,000); Credit Suisse (75,000); Alex. Brown & Sons (75,000); Deutsche Morgan Grenfell/C.J. Lawrence Inc (75,000); Donaldson, Lufkin & Jenrette (75,000); Hambrecht & Quist (75,000); Lazard (75,000); Merrill Lynch (75,000); Cowen (45,000); Interstate/Johnson Lane Corporation (45,000); KeyBanc Capital Markets (45,000); Needham & Company (45,000); Raymond James (45,000); Truist Securities (45,000); Stephens (45,000); Van Kasper & Company (45,000); Vector Securities International, Inc (45,000); Arizona Securities Group Inc (20,000); Burnham Securities, Inc (20,000); Shepherd Financial Group, Inc (20,000); Starr Securities, Inc (20,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Form 5500 plan sponsor: CASI PHARMACEUTICALS, INC. EXACT (EIN (EXACT))
• Form D issuer: ENTREMED INC EXACT (CIK (EXACT))
• SEC filer: CASI Pharmaceuticals, Inc. EXACT (CIK (EXACT))
• Person page: Wei-Wu He Phd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer,TenPercentOwner))

Filings 4

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), MD first:

• MICROMET, INC. MD
• OSIRIS THERAPEUTICS, INC. MD
• REGENXBIO Inc. MD
• ELUTIA INC. MD
• CHAMPIONS ONCOLOGY, INC. MD
• BioNTech SE 2M
• Immatics N.V. 2M
• CHEMOKINE THERAPEUTICS CORP A1
• Fusion Pharmaceuticals Inc. A6
• CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ

More with this interest.

In other datasets, the same topic (Health) in MD:

• Nonprofit: 4K FOR CANCER INC (Nonprofits (IRS Form 990))

Interests: Biological Products, (No Diagnostic Substances) · Health